Newshot
Account

New culprit in early Alzheimer’s: Blood–brain barrier blocks protective proteins

Summary

Nature, Published online: 11 November 2026; doi:10.1038/d41586-026-03655-2 The brain relies on crucial proteins to maintain neurons. This system is disrupted in mice with neurological disease.

Original text(via Nature)
Colourful 3D image of a human brain.
Colourful 3D image of a human brain.

Credit: K. H. Fung/SPL

For decades, scientists thought of the blood–brain barrier as an impenetrable layer. Overtime that view has changed, as researchers realized the barrier was more permeable than first thought. Now a team have catalogued almost 100 proteins that can pass through it to maintain brain health.1

The team also found that the transport of some of these crucial proteins breaks down in mice with brain disease that mimic early-stage Alzheimer’s disease.

“The paradigm in the field has been that the blood–brain barrier is normally impermeable and then becomes leaky as a result of Alzheimer’s disease,” says study co-author Andrew Yang, a neuroscientist at Gladstone Institute of Neurological Disease in San Francisco, California. Instead, his team’s work suggests that the blood–brain barrier actively imports proteins that the brain needs to function and the loss of these proteins drives the dysfunction seen early in the disease, he adds.

Labelling proteins

Yang and his colleagues developed a technique to label a large array of proteins in the blood and track those that can enter the brain. Of the 861 proteins they mapped, 92 crossed the blood–brain barrier into the brain. Most of these proteins were produced in distant organs, particularly the liver.

The team focused on apolipoprotein A1 (APOA1) which has been linked to potential protective effects against Alzheimer’s disease. Once inside the brain, APOA1 stimulates brain cells called astrocytes to release cholesterol, which is important for maintaining the synapses through which neurons communicate. But how the protein crossed the blood-brain barrier has been unclear until now, says Yang.

His team found that two receptors for APOA1 — SR-B1 and ABCA1 — are present on the blood–brain barrier as well as astrocytes. This suggests how the protein moves from the blood-brain barrier to the specific brain cells that need them, the authors say.

When Yang’s team blocked the ABCA1 receptor in laboratory-grown astrocytes, the protein no longer had the same cholesterol-regulating effects.

Alzheimer’s link

Scientists have long known that the blood–brain barrier breaks down as Alzheimer’s advances, letting harmful molecules leak into the brain. Yang’s team found that a different problem emerges first.

Using their labelling technique in a mouse model of Alzheimer’s disease, the researchers found that the blood–brain barrier stopped importing protective proteins such as APOA1 into the brain before the barrier began to break down. This disruption to the protein transport was accompanied by a loss of neuronal connections, behavioural changes and other early hallmarks of the disease.

Yang and the team wondered whether increasing the supply of APOA1 in the blood might help to counter some of the damage caused by Alzheimer’s disease. To find out, the team engineered mice with Alzheimer’s to produce extra APOA1 in the liver. When more APOA1 crossed their blood–brain barrier and entered the brain, the mice showed fewer Alzheimer’s-disease-related markers. For example, they had reduced fat build-up in astrocytes and lower levels of inflammatory molecules.

Enjoying our latest content? Log in or create an account to continue

  • Access the most recent journalism from Nature's award-winning team
  • Explore the latest features & opinion covering groundbreaking research

doi: https://doi.org/10.1038/d41586-026-03655-2

References

  • Zhou, H. et al. Cell https://doi.org/10.1016/j.cell.2026.10.039 (2026).Article Google Scholar

Zhou, H. et al. Cell https://doi.org/10.1016/j.cell.2026.10.039 (2026).

Article Google Scholar

Download references

Reprints and permissions

Subjects

  • Alzheimer's disease

Latest on:

  • Is social media changing children’s brains? Here’s what the science says Spotlight 04 NOV 26

Is social media changing children’s brains? Here’s what the science says

Spotlight 04 NOV 26

  • Fruit, flies and getting frisky: how food odours trigger sexual arousal News & Views 04 NOV 26

Fruit, flies and getting frisky: how food odours trigger sexual arousal

News & Views 04 NOV 26

  • Epileptic seizures nearly vanish after people receive experimental gene therapy in their brains News 04 NOV 26

Epileptic seizures nearly vanish after people receive experimental gene therapy in their brains

News 04 NOV 26

  • DeepMind's ultra-powerful AI for genome mapping wows scientists News 11 NOV 26

DeepMind's ultra-powerful AI for genome mapping wows scientists

News 11 NOV 26

  • Move over BMI: new obesity definition is better for predicting your health News 11 NOV 26

Move over BMI: new obesity definition is better for predicting your health

News 11 NOV 26

  • Validation of clinical and preclinical obesity across global cohorts Article 11 NOV 26

Validation of clinical and preclinical obesity across global cohorts

Article 11 NOV 26

Jobs

  • Associate or Senior Editor, Communications AI & Computing Job Title: Associate or Senior Editor, Communications AI & Computing Locations: Shanghai, Beijing, Pune, New Delhi, Berlin or Madrid (hybrid) Appli... Shanghai, Beijing, Pune, New Delhi, Berlin or Madrid (hybrid) Springer Nature Ltd

Associate or Senior Editor, Communications AI & Computing

Job Title: Associate or Senior Editor, Communications AI & Computing Locations: Shanghai, Beijing, Pune, New Delhi, Berlin or Madrid (hybrid) Appli...

Shanghai, Beijing, Pune, New Delhi, Berlin or Madrid (hybrid)

Springer Nature Ltd

  • Postdoctoral Fellow Postdoctoral Fellow focus on ferroic smart materials: shape-memory alloys, piezoelectric ceramics, and magnetostrictive materials, etc Ningbo, Zhejiang (CN) Center for Advanced Smart Materials (CASM), Yongjiang Laboratory (Y-Lab)

Postdoctoral Fellow

Postdoctoral Fellow focus on ferroic smart materials: shape-memory alloys, piezoelectric ceramics, and magnetostrictive materials, etc

Ningbo, Zhejiang (CN)

Center for Advanced Smart Materials (CASM), Yongjiang Laboratory (Y-Lab)

  • Principal Investigator/ Associate Professor PI & Associate Professor class focus on innovative research about ferroic smart materials or technology transfer Ningbo, Zhejiang (CN) Center for Advanced Smart Materials (CASM), Yongjiang Laboratory (Y-Lab)

Principal Investigator/ Associate Professor

PI & Associate Professor class focus on innovative research about ferroic smart materials or technology transfer

Ningbo, Zhejiang (CN)

Center for Advanced Smart Materials (CASM), Yongjiang Laboratory (Y-Lab)

  • Open-Rank Faculty Position in Basic Biomedical Research WashU Medicine’s Dept of Anesthesiology seeks applicants for a tenure-track or tenured faculty position in the Division of Basic Research. Saint Louis, Missouri WashU Medicine - Anesthesiology

Open-Rank Faculty Position in Basic Biomedical Research

WashU Medicine’s Dept of Anesthesiology seeks applicants for a tenure-track or tenured faculty position in the Division of Basic Research.

Saint Louis, Missouri

WashU Medicine - Anesthesiology

  • Global Recruitment of Outstanding Young Talents We are seeking exceptional candidates who qualify for the National Science Fund for Excellent Young Scholars (Overseas) 1068 Xueyuan Avenue, Shenzhen 518055 P. R. China Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences(CAS)

Global Recruitment of Outstanding Young Talents

We are seeking exceptional candidates who qualify for the National Science Fund for Excellent Young Scholars (Overseas)

1068 Xueyuan Avenue, Shenzhen 518055 P. R. China

Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences(CAS)

The text above was extracted automatically from the source page and may miss images, tables or code blocks. The original is authoritative.

Published by Nature
This site only summarises and aggregates; copyright stays with the original author. Headlines and summaries follow the source — where they differ, the original wins.
Read the original ↗